EDGAR Filing Documents for 0001193125-15-286517

Form 8-K - Current report:

SEC Accession No. 0001193125-15-286517

Filing Date

2015-08-11

Accepted

2015-08-11 16:49:06

Documents

Period of Report

2015-08-11

Items

Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d70872d8k.htm	8-K	21210
2	EX-3.1	d70872dex31.htm	EX-3.1	25355
3	EX-3.2	d70872dex32.htm	EX-3.2	154361
4	EX-99.1	d70872dex991.htm	EX-99.1	5766
5	GRAPHIC	g70872g57z26.jpg	GRAPHIC	5973
	Complete submission text file	0001193125-15-286517.txt		216343

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884

Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220

Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37519 | Film No.: 151044505
SIC: 2834 Pharmaceutical Preparations